Leflunomide vs methotrexate
Serious adverse events* · adults with renal vasculitis for maintenance therapy
Leflunomide showed no clear difference in serious adverse events* compared with methotrexate (low certainty).
1 finding from 1 review
- RR 11.81 [0.69, 203.68]1 study · 54 participantsLow